O. Altundag Et Al. , "Adjuvant targeted therapy with trastuzumab may decrease metastatic capacity in specific group of oropharyngeal cancer patients: downregulation of E-cadherin-catenin complex by cooperative effect of erbB-2 and human papillomavirus type 16 E6/E7 protooncogenes," MEDICAL HYPOTHESES , vol.63, no.2, pp.277-280, 2004
Altundag, O. Et Al. 2004. Adjuvant targeted therapy with trastuzumab may decrease metastatic capacity in specific group of oropharyngeal cancer patients: downregulation of E-cadherin-catenin complex by cooperative effect of erbB-2 and human papillomavirus type 16 E6/E7 protooncogenes. MEDICAL HYPOTHESES , vol.63, no.2 , 277-280.
Altundag, O., Altundag, K., Morandi, P., & Gunduz, M., (2004). Adjuvant targeted therapy with trastuzumab may decrease metastatic capacity in specific group of oropharyngeal cancer patients: downregulation of E-cadherin-catenin complex by cooperative effect of erbB-2 and human papillomavirus type 16 E6/E7 protooncogenes. MEDICAL HYPOTHESES , vol.63, no.2, 277-280.
Altundag, O Et Al. "Adjuvant targeted therapy with trastuzumab may decrease metastatic capacity in specific group of oropharyngeal cancer patients: downregulation of E-cadherin-catenin complex by cooperative effect of erbB-2 and human papillomavirus type 16 E6/E7 protooncogenes," MEDICAL HYPOTHESES , vol.63, no.2, 277-280, 2004
Altundag, O Et Al. "Adjuvant targeted therapy with trastuzumab may decrease metastatic capacity in specific group of oropharyngeal cancer patients: downregulation of E-cadherin-catenin complex by cooperative effect of erbB-2 and human papillomavirus type 16 E6/E7 protooncogenes." MEDICAL HYPOTHESES , vol.63, no.2, pp.277-280, 2004
Altundag, O. Et Al. (2004) . "Adjuvant targeted therapy with trastuzumab may decrease metastatic capacity in specific group of oropharyngeal cancer patients: downregulation of E-cadherin-catenin complex by cooperative effect of erbB-2 and human papillomavirus type 16 E6/E7 protooncogenes." MEDICAL HYPOTHESES , vol.63, no.2, pp.277-280.
@article{article, author={O Altundag Et Al. }, title={Adjuvant targeted therapy with trastuzumab may decrease metastatic capacity in specific group of oropharyngeal cancer patients: downregulation of E-cadherin-catenin complex by cooperative effect of erbB-2 and human papillomavirus type 16 E6/E7 protooncogenes}, journal={MEDICAL HYPOTHESES}, year=2004, pages={277-280} }